CYP4A11和载脂蛋白B、E基因多态性与原发性高血压患病风险的相关性

路轶晴

CYP4A11和载脂蛋白B、E基因多态性与原发性高血压患病风险的相关性

路轶晴

西安市第一医院心血管科

基金项目:

基金：国家自然科学基金资助项目 (81300115);

计量
- 文章访问数: 2048
- HTML全文浏览量: 736
- PDF下载量: 64
- 被引次数: 0
出版历程
- 收稿日期: 2018-02-11

Association Analysis between Genetic Polymorphisms of CYP4A11, Apolipoprotein B and E Genes and Essential Hypertension Susceptibility

Lu Die Qing

Funds:

基金：国家自然科学基金资助项目 (81300115);

摘要

摘要: 目的探讨CYP4A11基因和载脂蛋白B、E基因 (Apo B、Apo E) 多态性与原发性高血压之间的相关性.方法采用病例-对照的研究设计, 通过关联分析的研究方法, 严格按照标准选取2012年6月至2016年12月西安市第一医院收治的350例原发性高血压患者为原发性高血压组, 另选取350例于同时期在西安市第一医院行常规性检查的正常体检者为对照组, 采用Mass ARRAY方法对2组人群进行CYP4A11基因和Apo B、Apo E基因多态性检测, 用SPSS软件统计基因多态性与原发性高血压患病风险的相关性.结果通过比较各位点的等位基因频率, 研究结果显示, 在等位基因模型下, CYP4A11基因上的rs1126742 (OR=1.45, 95%CI, 1.091.92, P=0.008) 、rs3890011 (OR=1.98, 95%CI, 1.061.85, P=0.001) 以及rs9332978 (OR=1.54, 95%CI, 1.271.91, P=0.004) 这3个多态性位点会显著增加原发性高血压的患病风险;Apo B基因上的XbaⅠ多态性与原发性高血压的患病风险相关 (OR=1.55, 95%CI, 1.152.55, P=0.001) , Apo B基因上的Eco RⅠ多态性与原发性高血压的患病风险不存在相关性 (P>0.05) ;Apo E基因ε4多态性与原发性高血压的患病风险相关 (OR=1.49, 95%CI, 1.092.35, P=0.012) , ε2、ε3多态性与原发性高血压的患病风险不存在相关性 (P>0.05) .通过比较各位点的基因型频率, CYP4A11基因rs9332978位点的GG基因型、rs1126742位点的TC与CC基因型以及rs3890011位点的CG与GG基因型均可增加原发性高血压的患病风险 (P<0.05) ;Apo B基因XbaⅠ多态性位点的X-X-基因型能显著增加原发性高血压的患病风险 (OR=2.45, 95%CI, 1.253.25, P=0.035) ;Apo E基因的E2/E4、E3/E4、E4/E4基因型均能显著增加原发性高血压的患病风险 (P<0.05) .引入遗传模型分析后, 研究结果显示, 在隐性模型下, rs9332978的最小等位基因A与增加原发性高血压患病风险具有相关性 (OR=1.61, 95%CI, 1.282.03, P=0.001) ;rs1126742的最小等位基因T在显性和隐性遗传模型下均与原发性高血压患病风险显著相关 (显性模型:OR=1.45, 95%CI, 1.091.82, P=0.008;隐性模型:OR=1.37, 95%CI, 1.112.16, P=0.004) .结论 CYP4A11 (rs9332978、rs1126742和rs3890011位点) 基因以及Apo B (XbaⅠ) 、Apo E基因多态性在原发性高血压的发生发展中起着至关重要的作用.
- 原发性高血压 /
- CYP4A11 /
- 载脂蛋白B基因 /
- 载脂蛋白E基因 /
- 基因多态性
Abstract: Objective To investigate the association between single nucleotide polymorphisms (SNPs) in CYP4A11 and Apo B、 Apo E genesandthe risk of essential hypertension. Me thods By means of correlation analysis, this case-controlled study included a total of 350 essential hypertension patients admitted in the first Hospital of Xi'an from June 2012 to December 2016, and another 350 cases with matched ages and sexes enrolled for routine check-ups as the healthy control group. The genotypes of CYP4A11 and Apo B、 Apo E genes were determined by Mass ARRAY method. SPSS 21.0 software was used to determine the correlation between SNPs and the risk of primary hypertension.Re s ults Comparing the allele frequencies of SNPs, we found rs1126742 (OR=1.45, 95 % CI, 1.09-1.92, P =0.008) 、 rs3890011 (OR=1.98, 95 % CI, 1.06-1.85, P =0.001) and rs9332978 (OR=1.54, 95 % CI, 1.27-1.91, P=0.004) on CYP4A11 were significantly associated with an increased risk of essential hypertension; Xba Ⅰ polymorphism in Apo B gene was associated with essential hypertension risks (OR=1.55, 95 % CI, 1.15-2.55, P=0.001) ;ε4 in Apo E gene was also found associated with essential hypertension risks (OR=1.49, 95 % CI, 1.09-2.35, P =0.012) , while ε2 andε3 not associated.Comparing the genotype frequencies of SNPs, we found the GG genotype of rs9332978, TC and CC genotype of rs1126742, CG and GG genotypes of rs3890011 were associated with increased risks of essential hypertension (P <0.05) .The X-X-genotype of Xba Ⅰ in Apo B gene were associated with increased risks of essential hypertension (OR=2.45, 95 % CI, 1.25-3.25, P = 0.035) . The E2/E4、E3/E4、E4/E4 genotype of Apo E were associated with increased risks of essential hypertension (P<0.05) .In the genetic model analysis, we found that the minor allele "A" of rs9332978 was associated with an increased risk of essential hypertension under dominant model (P <0.05) . The minor allele "T" of rs1126742 was associated with increased risks essential hypertension under dominant and recessive models (P<0.05) . Conclus ion Gene polymorphisms of CYP4A11、Apo B and Apo E play an important role in the occurrence and development of essential hypertension.
- Essential hypertension /
- CYP4A11 /
- ApoB /
- ApoE /
- Ggene polymorphisms

HTML全文

参考文献(23)

[1]	[1]DAWES M, BRETT SE, CHOWIENCZYK PJ, et al.The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension[J].British Journal of Clinical Pharmacology, 2015, 48 (3) :460-463.
[2]	[2]AGARWAL A, AL E.Genetics of human hypertension[J].Trends in Endocrinology&Metabolism Tem, 2005, 16 (3) :127-133.
[3]	[3]WANG X, CHEN J, WANG Q, et al.Association between CACNB2 gene polymorphism and stroke of ethnic Han Chinese in Wenzhou region[J].Journal of Wenzhou Medical University, 2015, 8 (1) :39-41.
[4]	[4]KOSTULAS K, HUANG WX, CRISBY M, et al.An angiotensin converting enzyme gene polymorphism suggests a genetic distinction between ischaemic stroke and carotid stenosis[J].European Journal of Clinical Investigation, 2015, 29 (6) :478-483.
[5]杨夏, 张跃新, 朱滨.ACE基因型与脑中风的相关性文献研究[J].新疆医科大学学报, 2007, 30 (7) :746-748.
[6]	[6]JIANG X, SHENG H, LI J, et al.Association between renin-angiotensin system gene polymorphism and essential hypertension:a community-based study[J].Journal of Human Hypertension, 2009, 23 (3) :176.
[7]	[7]SOUSA AC, PALMA RDR, PEREIRA A, et al.Relationship between ADD1 Gly460Trp gene polymorphism and essential hypertension in Madeira Island[J].Medicine, 2017, 96 (42) :e7861.
[8]伊琳, 顾远晖, 周瑞霞, 等.东乡族原发性高血压血管紧张素转换酶基因多态性[J].兰州大学学报 (医学版) , 2007, 33 (1) :48-50.
[9]	[9]MORGAN S.Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls[J].New England Journal of Medicine, 1979, 300 (20) :1142.
[10]周冰, 何淑兰, 谭武红.花生四烯酸CYP表氧化酶代谢产物EET对心肌病的保护作用[J].国外医学医学地理分册, 2015, 36 (1) :66-70.
[11]	[11] GAINER J V, BELLAMINE A, DAWSON E P, et al.Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension[J].Circulation, 2005, 111 (1) :63.
[12]	[12]SHAHID S U, COOPER J A.Effect of SORT1, APOB and APOE polymorphisms on LDL-C and coronary heart disease in Pakistani subjects and their comparison with northwick park heart study II[J].Lipids in Health&Disease, 2016, 15 (1) :1-9.
[13]	[13]KRAUSE B R.The roles of apolipoproteins B and E in lipid transport and atherosclerosis[J].Drug Development Research, 2010, 6 (2) :155-165.
[14]郭利伟, 武红艳, 黄艳梅, 等.肿瘤坏死因子α及β基因多态性与河南汉族原发性高血压的相关性[J].新乡医学院学报, 2009, 26 (4) :352-354.
[15]张旺德, 何燕, 官志忠.e NOS基因多态性与原发性高血压的关系[J].贵阳医学院学报, 2016, 41 (1) :1-4.
[16]	[16]GAINER J V, BELLAMINE A, DAWSON E P, et al.Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension[J].Circulation, 2005, 111 (1) :63.
[17]	[17]WARD N C, TSAI I J, BARDEN A, et al.A single nucleotide polymorphism in the CYP4F2 but not CYP4A11gene is associated with increased 20-HETE excretion and blood pressure[J].Hypertension, 2008, 51 (5) :1393.
[18]	[18]LAFFER C L, GAINER J V, WATERMAN M R, et al.The T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension[J].Hypertension, 2008, 51 (3) :767-772.
[19]	[19]ZHEN-YAN F U, YI-TONG M A, YANG Y N.Association between the SNPs of human CYP4A11 gene and essential hypertension[J].Journal of Xinjiang Medical University, 2008.
[20]	[20]PHILLIPS C M, GOUMIDI L, BERTRAIS S, et al.Gene-nutrient interactions and gender may modulate the association between Apo A1 and Apo B gene polymorphisms and metabolic syndrome risk[J].Atherosclerosis, 2011, 214 (2) :408-414.
[21]	[21]HEIDARI M M, KHATAMI M, HADADZADEH M, et al.Polymorphisms in NOS3, MTHFR, APOB and TNF-αgenes and risk of coronary atherosclerotic lesions in iranian patients[J].Research in Cardiovascular Medicine, 2015, 5 (1) :e29 134.
[22]	[22]TANG LI YUAN, WANG XIAO TONG, KANG Y U.Correlative analysis of apolipoprotein B、E gene polymorphism and several common diseases in southern area of Zhejiang Province[J].Journal of Wenzhou Medical College, 2007, 9 (2) :27-31.
[23]	[23]CHEEMA A N, BHATTI A, WANG X, et al.APOE Gene Polymorphism and Risk of Coronary Stenosis in Pakistani Population[J].Biomed Research International, 2015, 2015 (15) :58-65.

相关文章(20)

[1]	齐汝楠, 史磊, 刘舒媛, 李菁, 史荔. HLA-DM基因多态性与脊髓灰质炎疫苗诱导抗体应答的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240102
[2]	马承娅, 杨江, 陈曦, 徐茜, 尹丕轩, 舒芯, 彭红瑜, 范志祥, 龙莉. 髓过氧化物酶-463G/A基因多态性与彝族原发性高血压的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240408
[3]	谭洪, 殷和佳, 李妍, 胡琴, 李斓, 任遵丹, 石柔. DDAH1基因836A/T多态性与云南地区汉族2型糖尿病肾脏疾病的相关性分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230621
[4]	陆小华, 袁洪新. BTLA、CTLA-4基因多态性与肝癌TACE联合靶向治疗疗效及预后相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230927
[5]	陈捷, 郭伟昌, 殷和佳, 严红霞, 张帆, 王尧乙, 李会芳. RANTES及其受体CCR5基因多态性及环境因素在昆明汉族T2DM发生中的交互作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210606
[6]	牛玲, 李博一, 张程, 马蓉, 唐艳, 刘方, 尹利民, 韩竺君, 苗翠娟, 张娴. 降钙素受体、维生素D受体基因多态性与昆明地区2型糖尿病合并骨质疏松的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211114
[7]	武力勇, 陈元, 楚天舒, 郑清文, 朱国富. 瘦素及瘦素受体基因多态性与冠状动脉慢血流现象的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210328
[8]	皮婷, 梁月琴, 丁莉, 杨玲, 向盈盈. 妊娠期女性MTHFR 677C > T基因多态性分布特征及其与妊娠高血压疾病的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210215
[9]	陈新元, 吴晖, 莫亚雄, 韩雁冰, 陈新利, 朱文叶, 黄蕊, 唐薇. NRG1-ErbB4基因多态性与局灶性癫痫易感性的关系, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210607
[10]	彭红瑜, 范志祥, 张延洁, 舒芯, 张馥麟, 龙莉. CYP11B2基因-344C/T多态与云南双河乡彝族人群原发性高血压的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210702
[11]	欧阳培刚, 张桂敏, 刘寅强. NAT2基因多态性与云南汉族华法林剂量的相关性, 昆明医科大学学报.
[12]	念馨. 金属硫蛋白基因G-201A多态性在2型糖尿病及原发性高血压的分布差异性, 昆明医科大学学报.
[13]	黄红. 云南汉族原发性高血压ACE基因多态性与厄贝沙坦降压疗效相关性, 昆明医科大学学报.
[14]	简斌. 云南汉族人群CYP2C19基因多态性分析, 昆明医科大学学报.
[15]	王祝君. β-烯醇化酶基因多态性与COPD骨骼肌萎缩的相关性, 昆明医科大学学报.
[16]	刘建兴. 云南汉族人群VKORC1 1173C/T基因多态性与华法林抗凝治疗维持剂量的相关性研究, 昆明医科大学学报.
[17]	刘玲. 云南省重症新生儿黄疸与Gly71Arg基因多态性研究, 昆明医科大学学报.
[18]	陈茜. CYP1B1 432C/G基因多态性与子宫内膜异位症易感性的相关研究, 昆明医科大学学报.
[19]	孟丽红. Nogo及雌激素受体基因多态性与多发性硬化的研究, 昆明医科大学学报.
[20]	. 维生素D受体基因多态性与汉族散发性乳腺癌的相关研究, 昆明医科大学学报.